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Introduction
I have had little question in my mind as to
which subject I was going to write on for my senior
thesis.

Even before I entered medical school the

subject of lymphogenous leukemia was one subject which
I had determined to learn as much about as I could

and if possible understand it.

Lympnogenous leukemia

was the cause of my father's death.

For three years

I saw the effects of the disease on him and was deeply

impressed by the inabllity of anyone to cure the
disease and the utter lack of knowledge as to what
the disease was a result of.

In this thesis I have attempted to review the

ideas of o thers on those same two questions:

What

1s the cause of 1ymphogenous leukemia and what has
medical science to offer as treatment for the patient
suffering from this disease?

In pr·eparing the material for this thesis, I

am indebted to the manogram prepared in 1938, by
Forkner on leukerr.ia and associated diseases.

I have

reviewed the relative mat\:rnial in his bibliography and
expanded on it in an attempt to incorporate the

work and op1:1ons of otber men who wrote on the subject

and were not reviewed by him.
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Definition:
Lymphogenoue leukemia is an invariably fatal
disease of uncertain etiology, characterized by wide
spread hyperplasia of lymphoid tissues accompanied
by generalized lymphadenopathy, rapid, and disorderly
proliferation of lymphocytes and their precusors
and by the presence, almost without exception, at
some time during the course of the disease, of immature,
small leukocytes in the blood often in very large.
numbers and their deposition in the various tissues.

-3Historical Review of Lymphogenoue Leukemia:
Since the diagnosis, symptoms and evidence of
lymphogenous leukemia is recognized today, it is
possible in retrospect to find d�scriptions of the
disease, unre�ognized but described, in the literature
of medical authors dating back almost to the time of
Hippocrates;

During these ancient times the authors

described fatal diseases in which the blood suggested
that ,,f;). was mixed with pus and the disease was associated,
frequently, with enlargement of the splee9.

The

clinical d�criptions of some of these cases suggested
that the d&:.scriptions were of leukemia.
In Febuary, 1841, Craigie (I•) attended a patient
who presented the clinical symptoms and physical
findings of a patient who had leukemia.

This patient

died the following April of the same year and on
autopsy be found a spleen which weighed seven pounds,
three and a half ounces as compared with its liver
which weighed six pounds, three ounces.

Ha states

that, "a considerable quantity of pink wine lee coloured
groumous blood, semifluid and imperfectly coagulated,
mixed with whitish-coloured masses pf purulent lymph,
was found in the inferior vena cava and in the mesenteric
veins."
In Feburary 1845, Bennet(4) observed a case

-4which was very similar to that of Craigie's.

He

also believed that death was a result of purulent
matter in the blood but he noted that purulent matter
existed in the blood, "notwithstanding the absence of
any recent inflam�ation, or collection of pus in the
tissues.

11

He noted tha t the liver was enlarged and

weighed ten pounds twelve ounces.

The spleen was

described as,"enormously enlarged from simple hypertroph y."
This spleen weighed seven pounds and twelve ounces.
Virchow(:7) in 1845, described a similar case.
Significant among his observations was his d'1.scription
of the blood in which he observed that the proportions
between the number of red and white corpuscles seemed
to be reversed and this resulted in a grayish-white
"P
appearance of the blood. He tberefore prspo$ed
the
name of ''Weisses Blut" or
the disease.

11

LeukHmie 11 to be given to

His atacription is the first in which

microscopic analysis of the blood rev.Nled white blood
in preponderance and the gr,oss description of "purulent
blood" was not used.
Until this time the altered condition of the
blood had been recognized only a�ter death.

In

January 1846, a case occured in St,. George's Hospital
in which the liver and spleen were greatly enlarged.

Dr. Fuller(l9) demonstrated in this patient during life
and after death, that in the blood there was a lar.ge
proportion of abnormal colorless globules.
In August 1846, Dr. Walshe(22) demonstrated that
the blood of a patient which enlargement of the spleen
contained as many colorless corpuscles as colored discs.
In 1846, Virchow(58) published articles in which
he argu�d that the abnormal cells in leukemia were
really white blood cells and not pus cells as formerly
was contended.

He' pointed out the relationship between

the process of the disease and pathology of lymphnodes.
He was the first man to distinguish between types .of
leukemia, dividing it into two classes, splenic and
lymphatic.
Following Ehrlich's demonstration in 1891, on
the differential staining of blood cells by use of
specific staining reactions, the differentiation
of lymphogenous leukemia from other forms of the disease
has been made possible on a basis of blood findings.
This aided greatly in simplifying the diagnosis of
lymphogenous leukemia.
Even after using Ehrlich's method, it is difficult
sometimes to differentiate between myelocytes and
lymphocytes on blood smears.

Graham(23) in 1916,
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described a method of differentiating between these
cells.

He described an oxidizing ferment which was

present in the myelocyte series and which was absent
in the lymphocytes.

This ferment activity makes itself

evident by a deep violet coloration of cells when
alphanaptholpyronin is used( ),meare of these eelle.
No reaction occurs in lymphocytes which do not contain
this oxidizing ferment.
Goodpasture(21) in 1918, also contributed to the
accurate diagnosis of lymphogenous leukemia by
laboratory means using oxydaee and peroxydase staining
properties of the blood cells.
It is evident that the history of lymphogenous
leukemia has a long 4uration.

In the early history

the disease was not differentiated from other types
of leukemia.

The first differentiation was made on

a clinical basis, followed shortly by refined laboratory
proceedures which have been perfected to a high and
corr,plicated degree of perfection.
This disease has been recognized for a long period
of time and has attracted the attention of numerous
investigators but our knowledge of its origin and
adequate means of combating it have advanced but
little.

-7The Etiology of Lymohogenous Leukemia:
What is known of the etiology of lymphogenous

leukemia?

In the definition of this disease it was described

as a disease, "of uncertain etiology.''

This state-

ment is true in as much as no person has ever established
any agent or condition as specifically resulting
in the disease in humans.

It is also true that a

great amount of investigation has been carried out
to determine what the etiology is and many significant
facts and opinions have been uncovered which are
of an aid in attempting to understand what the etiology
might be
Occurrence

!n Animals Oth'9r Than Man:

Lymphogenous leukemia is a disease which is

common to b oth man and other animals.

Even before

lymphogenous leukemia was classified separately

from other types of leukemia in man, Leisering(31)

in 1858, discovered leukemia in animals.

This is

but a few years after the disease was first recognized
as an entity in rr.an.

•

The first lymphogenoue type of leukemia which
was described in animals was found in the dog by
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Lildke(35) 1n 1910.

Wirth(63) in 1920, described

cases of lymphogenous leukemia in dogs.

Wirth and

Baumann(64} 1n 1933, again described cases of lymphogenous
leukemia in doge.

There can therefore be little

question on the existance of the disease in this
animal.
In 1923, Massaglia(37) studied a monkey which
he reported as suffering from a disease which very
closely resembled lymphogenous leukemia in man.
In 1932, Barile(3) studied the reported cases

of lymphogenous leukemia which had been described
in the literature as occurring in the horse up to
tha t time.

He concludes that the disease as such

has been demonstrated to exist in that animal.

These are but examples of the demonstrated
ex1stance of lymphogenous leukemia in other animals
and serve to prove that lymphogenous leukemia is

not a disease of man alone but occurs in many other

animals as well.

A great number of accounts of the

existance of lymphogenous leukemia in other animals
is to be found in the literature but review of them
here would serve no wotbhy purpose.
Incidence

in. Man:

In attempting to evaluate the incidence of
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lymphogenous leukemia it is well to keep in mind that
any disease which is surrounded with such mystery as
to its etiology and with such unsuccessful therapeutic

results will naturally demand the attention of investi
gators and will be more frequently reported than
will be the more comrrion diseases.

The end result of

this situation is to distort the statistics of the
incidence of this disease to the extent of making
its occurrence seem more prevelent than it actually
is.

Thus among 25,246 cas�s in the Babie's Hospital

in New York City, Wollstein and Bartlett(65) in

1925, observed fourteen instances of acute lymphogenous

leukemia.

In 1931, Ikeda(27) found record of fifty-one

cases of lymphogenous leukemia in the 12,396 necropsy

records of the University of Minnesota.

Here again

we must re�ember that lymphogenous leukemia deaths

are more frequently autopsied than are ca�es of death
from more com�on causes.

In 1935, Rosenthal and Harris(48) reviewed

455 cases of leukemia and found seven per cent of
these were acute lymphogenous leukemia and twenty and
six-tenths per cent were chronic lymphogenous leukemia.
The remaining cases were twenty-nine and four tenths
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per cent acute myelogenous, one and a half per cent
acute monocytic, thirty-four and a half per cent
chronic myelogenous, four tenths per cent chronic
monocytic, two and two tenths per cent erythroleukem1a,
six tenths per cent eosinophilic and one and three
tenths per cent aleukemic leukemia.

From this study

and others, it is evident that the incidence of lympho
genous leukemia is not so great as is that of myelogenous
leukemia in ·both its acute and chronic forms.
Panton and Valent1ne(42) in 1929, reviewed the
records of the lymphogenous leukemia patients treated·
in the London Hospital between 1912, and 1927, and
made note of the fact that nine out of thirteen cases
were among the Hebrew race.

They concluded that,

"The Hebrew race is particularly susceptible to this
disorder. 0
Hereditary Aspects:
What is the role of heredity of lymphogenous
leukemia and of What etiological significance ls
hereditY,1

This ls a question which has rec1eved a

great deal of attention by all persons interested in
this disease.
As far back as 1888, Cameron(6) reported a case
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of leukemia in which a mother, grandmother and brother.
had symptoms of leukemia as we�l as two of the mother's
children.

H� did not report which kind of leuke�ia

these patients suffered from and since they all showed
evidence of Jaundice, it is possible that he was ob
serving a case of familial hemolytic Jaundice rather
than leukemia.
Richards (46) in 1921, reported two cases in one
family in which one was clinically diagnosed as lympho
sarcoma with a white blood count of 24,000, and the
other as lymphogenous leukemia with a white cell count
of 41,400.

He concluded that the relationship was

probably close between the two diseases and that the
familial occurrence of the diseases was significant.
McGovan(38) in 1922, reported three cases of
leukemia, two of which were lymphogenous and on which
was myelogenous in one family.

The case seen by him

was a case of lymphogenous leukemia wh9 had a brother
who died of myelogenous leukemia and an uncle, on his
father's side, who died of lymphogenous leukemia.
He stresses the significance of the role of heredity
as a factor in leukemia.
Dameshek, Savity and Arbor(,�) in 1929, reported
the occurrence of chronic lympbogenous leukemia

-12simultaneously in identical twins, age 56, at the Boston
City Hospital.

They also concluded that the occurrence

of lymphogenous leukemia in identical twins was more
than coincidental and suggested the possibility of
an embryonic rest or anlage as the etiology.
Schereschewsky(50) in 1926, reported the appear

ance of chronic lymphogenous leukemia in a brother
at 61 years of age and a sister at 54 years age.

These

cases appeared almost simultaneously.
Burger(5) in 1927, reported the occurrence of
acute lymphogenous leukemia in two infants of the

same family.

Siegel(53) in 1928, in the Metbodist-Episcop&l
Hospital in Philadelphia, reported cases of chronic
lymphogenous leukemia existing simultaneously in twins
of opposite sex.

This set of twins was two and a half

years of age.
Sly(55) in 1931, discussed the relationship of
heredity and the occurrence of leukemic disorders
of malignant types.

She concluded on a basis of her

investigation carried out on r�ts and her review of

the literature, that these disorders are inherited

as a simple mendelian recessive and that the tendency
opposing these disorders acted as a simple mendelian
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dominant.

She supplied extensive records of families

of experiirental rats and her results were mathematically
in a mendellan ratio.
Sly's conclusions were sharply denied by Richter·
and MacDowell(47) because she failed to report on all
of her findings.

They charge that she failed to

report on the bulk of her results, reporting on only
44 out of 975 experimental tests.

They charge that

she failed to report on her negative results.

Further

more they contend that the generic conditions of the
animals used in her tests were not adequately controlled.
Their experiffiental examinations on rats whose generic
purity was assured by six years of inbreeding did
not confirm her results.
Age and Sex Occurrence:
The age at which acute and chronic lymphogenous
leukemia occur and a comparison of its incidence in
the two sexes is of interest and perhaps lends some
indication relative to the underlying eti�logy of
this disease.
One of the outstanding studies on this subject
was made by Ward(59) in 1917.

In his study on age

incidence and sex incidence of acute leukemia, he
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did not differentiate between lymphogenous and other
types of leukemia.

In his study of chronic leukemia

he did differentiate lymphogenous leukemia from the
For his study he reviewed

other types of leukemia.

398 cases of acute leukemia and 84 cases of epronlc
He reported these as to number

lymphogenous leukemia.

of cases and their age group, which he divided into
five year periods.
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-15Ward also tabulated the percentage incidence

of acute leukemia and chronic lymphogenous leukemia

for males and females in five year age periods.

tabulation 1n percentages are in the table below.
Age

-Group
5
10
15
20
25
30
35
40
45
50
55
60
tl35
70
75
80

Acute Leukemia

Male Female
60,%
65
69
72
71
71
70
69·
68
68
67
67

40%
35
31
28
29
29
30
31
32
32
33
33

His

Chronic Lymphogenous
Leukemia
Male Female
- -%

75
80

83

81
76
86
75
77
75
77
73
74
74
75

--'I,

25
20

17
19
24
14
25
23
25
23
27
26
26
25

In 1924, Minot and Isaacs(40) reported and

tabulated the age incidence of ninty-two cases of chronic
lymphogenous leukemia and demonstrated that the age
of selection of this disease was predominently about
forty-five to fifty-four years of age.
are charted on the next page.

Their results
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Likewise Minot and Isaacs reported and charted
the age incidence of acute lymphogenous leukemia.
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Minot and Isaacs reported on ninty-two cases of
chronic lymphogenous leukemia with reference to the
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sex incidence.

They found that of these, sixty-

eight or seventy four per cent were males while twenty
four or twenty-six per cent were females.
These two rr:en reported, in the same article,
a record of 256 cases of chronic lymphogenous leukemia
which were reported by Cabot, Vogel, Ward and them
selves and found th at the ratio of incidence among
men and women was cloae to three to one.
In a group of fifty-seven cases of acute lympho
genous leukemia, Minot and Isaacs report forty-five
cases or seventy nine per cent were in males while
twelve or twenty-one per cent were in females.
These rr.en feel that the statistics which they
present do not discriminate between the two sexes
as there 1s no evidence that lymphogenous leukemia
runs a different course in males and females.
Association and Relation to Neoplasia:
Should lymphogenous leukemia be classified as
one of the varieties of neoplasia?

This is another

of the great questions concerning this disease.
Some authors charge that classifying it as one of the
varieties of neoplasia is just a method of hiding
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our lack of knowledge of the etiology of this disease
while others claim that the characteristics and occur
rence of this disease along with neoplasms Justifies
such a classification.
Earlier in this thesis evidence was presented
to the effect that in families where neoplastic diseases
were found, it was not unconm on to find lymphogenous
leukemia. Example of this is the family case reported
by Richards ( �6).
Mallory(36) in 1914, was very outspoken on this
subject.

He collects the rr:alignant diseases ·· arising

from lymphoid tissue and collectively calls them
"lymphoblastoma."

He declares, "The lymphoblastoma

appears under various forms and ls known by a number
of different names, such as lymphoblastoma, lympho�a,
lymphocytoma, lymphoaarcoma, small round cell sar·coma,
pseudoleukemia, lymphatic leukemia and Hodgkin's
disease.

This variety of names ls partly the result

of the different clinical pictures presented by the
tumor as the consequence of location, rapidity of
growth and manner of spre·ading, and partly the result
of the lack of distinctive peculiarities which would
render the exact nature of the tumor recognizable
under all c onditions. 11

-19-

He believes that in lymphatic leukemia, the cells
of the lymphoblastoma gain access to the blood by
way of the lymphatics of the thoracic duct, by immi
gration into blood vessels, or by direct growth of
the tumor through a vessel wall into a vein or artery.
He also notes that �pparently some times the lympho
blastoma begins in the circulating blood because
in some instances no tu�or mass can be found as a
starting point.

Fuchs{l8) in 1927, reported on a case of lympho
genous leukemia in a patient who also had a basal
cell carcinoma.

Furth, Rathbone and Seibold(20) in 1932, made

an extensive study of transmissible lymphomatosis.

Under this term they collectively referred to lympho
genous leukemia, subleukemia, lymphomatosis, lymoho
sarcoma and leu.kosarcoma.

Collectively they referred

to the cells in these processes as being malignant

cells.

They thereby+ expressed their assumption that

these processes were closely related and that. they
were all malignant.
Schre1n�r and Wehr(�2) in 1934, made a study
of the association of cancer with leukemia.

They

studied 11,212 cases of malignancy and observed only
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four cases in which the malignancy was associated with
a leukemic blood picture.

Of the malignancy cases,

thirty-eight were recorded as chronic lymphatic leukemia.
Between the time they prepared their report and the
time they printed, they saw two more cases of malignancy
associated with lymphatic leukemia.

Of the four cases

they reported, two were cases of malignancy complicated
by lymphatic leukemia and two cases complicated
with aleukem1c leukemia in which the lymphocytes constituted
more than half of the white cells.

The malignancies

they reported complicating lympbogenous leukemia were
one ep1thellioma of the ear and a primary carcinoma
of the lung.

The malignancies reported with aleukemic

leukemia were carcinoma of the breast 1n a man and a
basal cell carcinoma of the bridge of the nose.

They

concluded that the association of a leukemic blood
picture w ith malignant disease was rare.

Hoffman(26) in 1934, had found but one case of

malignancy associated with eighty-six cases of lympho
genous leukemia seen by him at the Memorial Hospital
in New York City.
IsrHels(28) in 1940, pointed out that on a basis
of his experiments and the experiments of others,
that the properties of cells involved in leukemia
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of all types and in malignant processes are different
and therefore it would still seem unwise to assurr.e
that leukemia is an example of neoplasia.

When we consider the relatively small number
of cases of lymphogenous leukemia associated with
neoplastic diseases compared with the large number

of cases in w hich lymphogenous leukemia is not associated
with neoplastic diseases, it appears that the association
is more of a rarity than a general rule.

The

relationship of lymphogenous leukemia to neoplastic
diseases of lymphoid origin seems Justified only in
a manner of classification based on a com�on origin
of these cells.

It is not justified if classified

on a basis of comparitive functions, processes and
properties of cells in lymphogenous leukemia and

neoplastic diseases of lymphoid origin.
Relation to Trauma:

There are many cases reconded of myelogenous

leukemia which occurred following trauma, usually
involving breaking of bones.

Whether or not this is

of ettological significance is sometimes questioned.
There are not, however, any accounts of lymphogenous
leukemia recorded in which trauma was implicated in
the English literature.

-22Relation to Infection:
As

was pointed out in the historical review of

lymphogenous leukemia, from earliest times leukemia
was regarded as a disease in which, "purulent blood"
was considered to characterize the disease.
Almost every type of organism has been discovered
in patients suffering from lymphogenous leukemia
and an etiological significance has been ascribed
to them.
Forkner(l6) quoted numerous foreig� investigators
who, during the nineteenth century, reported finding
small bacilli, micrococci, coccobacilli and staphlo
cocci in the blood and tissues of patients suffering
from various types of leukemia.
Churchill(9) in 1904, reported on a case of
acute lymphogenous leukemia and reported finding the
presence of streptococci in the blood of the patient
both during life and at post-mortum.

He pointed out

also, that the same finding had been made in other
cases and he suggested that the finding was of etiolog
ical significance.
In 1912, Dietrich(l2) attributed etiological
significance to the tubercle bacillus in lymphogenous
leukemia.

-23Caver(8) in 1936, reviewed the history of a patient
who was known to have an old tuberculous scar in his
lung and who was, at the time be examined the patient,
presenting the symptoms and signs of having a tuber
culous laryngitis along with chronic lymphogenrus
leukemia.

He concluded that upon a basis of h is experience

that, "there is considerable clinical evidence irr.pli
cating tuberculosis as a possible etiological agent."
In 1914, Steele(56) isolated a diphtheroid bacillus
from one case of lymphogenous leukemia and also from
a case of Hodgkin's disease.

He pointed out the

fact that this organ1srr. was morphologically similar
and bad similar cultural characteristics to organisms
described and cultivated by Negri and Mieremet,
Bunting and Yates, and Billings and Rowenow which
they bad isolated from similar diseases.

He sugbested

an etiological implication of the orga.nism.
In 1915, Simon and Judd{54) described an organism,
which they called 6orynebacter1um lymphomatos1s
granulomatose, which they had isolated from a case
of acute lymphogenous leukemia and which, they point
out, is similar to the organism found by Steele.
They feel that these findings were not just coincidence
and suggested that it �ay be the etiological factor.
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Wilbur(62) in 1915, collected data which he
presented to the sixty-sixth annual session of
the American Medical Association in which he contended
that a diplostreptoccus was the etiological agent in
leukemia and pointed out the importance of taking
care of foci of infection in this respect.
Mcintosch(39) in 1933, expressed the veiw that
leukemias including lymphogenous leukemia, were caused
by a specific virus.
Reynolds(45) in 1933, suggested that cases
of acute lymphatic leukemia attended by him had their
etiology in frequent attacks of malaria.
White and Pr8scher(61) in 1907, reported a
case of acute lymphatic leukemia with characteristic
symptoms.

On aspiration of a lymph gland of this

patient, a large number of spirochetes were found.
On frozen section, stained by Levaditi's pyridin
silver method, innumerable spirochetes were found.
From this patients history, there was no trace of
syphilitic infection.
It is strange that with the large number of
different organisms which have been reported in patients
with lymphogenous leukemia that there is no account

-25of attempts to fulfill the postulates of Koch in
regarding them as an etiological agent.

Undoubtedly

this has been attempted but no success has been
met with.
Relation to Chemicals and Toxins:
Lignac(32) in 1928, inoculated white mice with
benzol in olive oil in repeated small doses.

In

one series of six animals inoculated from five to
thirty-three times, lymphoid hyperplasia of the spleen
was noticed bµt the mice did not have leukemia.
In a subsequent experiment Lignac (33) in 1932,
inoculated fifty-four adult mice with 0.001 cc. of
benzol in oil.

Of these eight developed leu�emia

from four to eleven months after the onset of the
experiment.

One mouse had lymphoblastic leukemia,

two had aleukemic lymphatic leukemia, two had mast
cell leukemia, two bad aleukemic mylos1s and one had
eosinophilic leukemia.
The tissue from one of the cases of aleukemic
mylosis was inoculated into another mouse which developed
lymphatic leukemia four months later.
Pent1mall1(43) in 1924, conclud�d, on a basis
of his experiments with the injection of various proteins,
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that intoxication is the cause of leukemia.

Dr. Rubnitz(49) of Omaha, in 1929, expressed the

opinion that acute leukemia, both lymphogenic and
mylogenic, was caused by a toxin similar to that
causing agranulocytosis.

He believes that in the two

conditions, the toxin differs only in quantity.

He

s uggests that the quantity of toxin is less in acute
leukemia, resulting in stimulation of white cell
production rather than d�struction as in agranulocytosis.
Falconer(l5) in 1933, presented a case in which

a worker was exposed to the f umes of benzol at his
place of employment.

He subsequently developed lympho

genous leukemia and died.

Falconer suggests that the

irritation or over stimulation of this chemical on the
lymphoblastic tissue might have been the cause of
his lymphogenous leukemia •

. Emmel(l4) in 1938, reported on his experiments

designed to produce leukemia in animals.

He claims

that his work shows a new fundamental principle of
self-perpetrating tissue autolysis as a basic process
involved in experimental leukemia, of all types, in
the chicken, dog, monkey, bog, goat and sheep.

He

showed that tissue autolysis leading to leukemia has
been initiated by the intravenous injection of living

-27and heat killed species of paratyphoid and typhoid
groups of bacteria in all of these species; also
freshly emulsified, desiccated and autolyzed homologous
tissues in the chicken, dog, monkey and goat.

He

also initiated the process by use of chemicals, using
benzene, phenol and xylol.

He states that the funda

mental nature of the process was similar in all instances.
He further believes that leukemia and cancer differ
only in that one is a disease of dynamic and the�
other of fixed tissue.
Relation to Irradiation:
Amundsen(2) in 1924, made a study of the blood
pictures shown by persons who were closely associated
with radiology.

She concluded that the blood picture

of radiolo.gists and their personel always shows a
deviation from the normal and the change is most
marked in the ratio of the poly�lear leukocytes to
the lymphocytes.

She found a reduced percentage of

polynuclear leukocytes and an increased percentage of
lymphocytes resulting in a relative lymphocytosis.
She noted that relative lymphocytosis was more marked
in persons who had been associated with x-ray work
for longer periods of time and that this feature would

-28-

disappear if these people would take a long vacation
and stay away from x-ray work dur�ng that time.
Carman and Miller(7) in 1924, at the Mayo foundation
also noted the relative lymphocytosis exhibited by
radiologists.

They also reported on th_e death of a

radiologist who was involved in fluroscopto work.
He was not punhitious as to protection and frequently
omited wearing an apron while he worked.

This man

developed typical lymphogenous leukemia f

These .

investigators also pointed out that the deaths of

radiologists are often reported without any information
as to their cause.

They questioned whether or not

lymphogenous leukemia might be somewhat of an
occupational hazard among radiologists.
Davey and Whitby(ll) in 1927, presented a record

of a medical man who died·from acute lymphogenous leukemia.
This man had worked for years with x-ray.

The type

of leukemia was confirmed on a basis of the oxidase
staining method.

These men also suggested that there

might be some relationship between his work with
x-ray and the cause of his death.
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The Treatment of Lymphogenoue Leukemia:
In the treatment of lymphogenoue leukemia we
are unable to apply the principle of combating the
etiological factor as we are attempting to treat a
disease in which tbat e·tiolog1cal factor is obscure.
Because of this it is necessary to treat this disease
symptomatically and that 1s the end to which all
ther2';y 1n lymphogenous leukemia is directed.
General Considerations:
The patient suffering from lymphogenous leukemia
frequently first notices fatigue as or?-of his first
symptoms.

This fatigue is probably the result of

the anemia which is associated with this disease.
Because of the fatigue it is usually necessary to
limit the patients activity.

This W8Uld mean that

the patient should not engage in the more vi�rous
sports and his occupation or type of work should
not be one conducive to fatigue.

This by no �eans

implies that the patient is to be an invalid but
that his activities should be limited so that he does
not suffer from fatigue.
The patient typically has an elevaiea basal
metabolic rate and this requires a diet which will
supply his basal need of energy and the additional

-30-

energy for his activity.

It is usually suggested that

a diet high in fat be given because of its high caloric
value and because the patient frequently io em�ated
from the excessive �etabolism of his own fat.

The

protein in the diet should be diminished prior to
arsenical and irradiation therapy because the patient's
endogenous protein metabolism is elevated following
_such treatment as the body proceeds to remove the
broken down protein of irradiated lymphoid tissue.
There is no need to select any particular type
of climate for these patients although rapid elevations
and depressions in temperat.ure are to be avoided as
it appears to render these patients more susceptible
to secondary diseases which are poorly handled by these
patients.
The patients suffering from lymphogenous leuke,mia
frequently suffer from ulceration of mucosal surfaces.
This is quite rearked in the oral cavity and infection
with fusiform bacilli and spirochetes frequently is
seen.

This is to be guarded against and treated if

tt does occur.
�-Ray Therapy:
The use of x-ray irradiation in the therapy of
lymphogenous leukemia seems parpdoxical in view of
-�
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the evidence presented in the discussion of the etiology
of the disease, where x-ray radiation was suggested
as a possible cause for this same disease. Notwith
standing this situation, x-ray therapy is excepted as
good therapy in this disorder.
Heineke(25) in 1904, demonstrated 1n animals
that the lymphoid organs were remarkably sensitive
to x-rays.

He demonstrated di-struction of the nuclei·

of'lymphocytes and of the follicles of lymph nodes.
He noted th at after stopping radiation, there was a
rapid regeneration of blood-forming tissue but also
that excessive radiation resulted in the disappearance
of white cells in the circulating blood.
It is the principle of decreasing the amount
of lymphoid tissue both in circulating blood and in
fixed tissues that is used in x-ray therapy in
lymphogenous leukemia.
In 1924, .Minot and Isaacs(40) reported, "Ir
radiation by roentgen-rays and radium is a form of
therapy that often brings relief to patients with
chronic leukemia though it does not cure either the
lymphatic nor myelogenous form.

It produces distinctly

more benefit in myelogenous than in lymphatic leukemia."
They con�lu�e that on a basis of their results and

-32the results of others, that a very high percentage
of the irradiated cases were distinctly and markedly
benefited but that irradiation had no detectable
effect on prolonging the duration of either form
of lymphatic leukemia.

They state, "The average

duration of life, after the first symptom of eighty
chronic cases, over thirty years of age, was 3.45
years, being essent�ally the same for the fifty irradiated
and the thirty that were not."
Minot and Isaacs(40) prepared a chart in which
they represented the duration of ei�hty-seven cases
of chronic lymphatic leukemia patients who were
treated by x-ray therapy.

They plotted these �n

age groups and the duration repr9sents the time between
the diagnosis of the dise·.se and death.

They also

plotted the rel tive ti�e at which therapy was started
on tbe sarra chart.

:, reDroduction of that chart is

shown on the following page.
These sair,e ILen charted the duration of lymphatic
leukemia on a basis of percentage of cases and length
o� time between the diagnosis and death o� the pat:ents.
This study was made on the same patients used in the
preceeding chart.
following page.

This chart also appears on the

..
'°
I

'�

c...

J

.

....

""'

�

11

-

-

I

0

r--.,
r---,

s
(JI

\�

.Sf

·�

�

/

r-----,.---,---.---- OS

O'C

,:t>
G\

02

"'
�
�

"'"'1

()

ol, �
'N

.,_,_.,r N• l.l t,10 Q11 t

IOINI/II J. ti llt/1.l J•.-�9At,,--••··••-•••
'NOIJ.Yas"a 1,v.1A If ---

'·•.

os

\.'·

·•. ..

'·

t--+-t�--+���----+---lo�

-33There is some argurr.ent
of using x-ray therapy.

RS

to the proper manner

In general there are about

Rs rr.any d1f�erent interpretations of the proper pro
ceedure to deliver this therapy as there are radio
logists in the field.

There many different typ�s

and degrees of filtration of the x-ray, and IDB:IlY different
voltages currently in use.

Some radiologists prefer

to irradiate only the local regional lymph nodes,
others prefer to irradiate the whole b_ody.
Harrison and Reeves(24) in 1939, reported on
treating twelve eases of lymphocytic leukerriia by
x-ray therapy.

They used bpth the local method and

the "sprAy method" in which the whole body was irradiated.
They expressed their belief that the "spr11y method"
of therapy was better because their patients, so
treated, were symptorr.-free for longer periods of tirr;e
and developed resistance to tbe rays more slowly

than the patients treated qy "local treatment" methods

and thus were carried over a longer period of time.

Dowdy and Lawrence(l3) in 1941, presented their
technic of roentgen-ray therapy for cases of chronic
leukemia.

They believe that in cases of chronic

lymphogenous leukemia, the p· tient should recleve
small doses of fifty to twenty-fiv� roentgens g1ven
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on succeeding days or shortly spaced intervals of time
till a total o f not more than 6:0 roentgens are delivered.
This should be followed by a period o� rest and again
resumed when the blood picture and symptomatic indications
are again present.

They believe that thls type of

treatment should be made locally over the enlarged
lymphoid tissue or treated by the quadrant technic
where t he mediasU:nal and deep abdominal lymph nodes
are primarily involved.
The argument they present is that since therapy
does not prolong life, but Just improves the efficiency
of the patient, he should not be subjected to massive
dosage therapy which makes the patient feel poorly
from the toxic action of massive tissue distruction.
These rr,en claim that by their method, the patient's
efficency can be increaEed by approximately sixty
per cent.
These men also say that acute leukemia should
not be treated with roentg�n rays, as ther·e is seldom
much response.

This seem to concur with the opinion

of almost all radiologists who have worked with
acute leukerria.
Pope and Watkins(44) in 1941, pointed out the
danger of large dosages of x-ray radiation in chronic
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macrolymphocytic and mesolymphocyt1c leukemia.

They

objected to the drastic depression of tbe white cell

count by such therapy and pointed out that by this

therapy that the cell count dropped sometimes from
162,000 to 29,300 cells in three days following

treatment.

Thet advised small dosage therapy, not

exceeding 100 to 125 roentgens per exposure and careful

study of blood smears of the patients to preveht

such drastic distruction of lymphocytes and their

precursors.

It is not the purpose of this t hesfs to enter

into a discussion of the action of the x-rays on lymphoid
tissue in this therry•

The the}ies on this subject

are numerous and are all of academic interest only.
Radium Therapy:

There is a good deal of literature written about

the use of radium in the therapy of myelogenous leukemia
where it can be used locally over the spleen, liver
and bone marrow.

On the other hand, there is very

little written about its use in the treatment of

lymphogenous leukemia.

The reason for this is obvious

for 1n lymphogenous leukemia we are concerned with
a disease wherein the hyperplasia of the lymphoid

tissue is generally distributed o�er the body rather

-36than the localized hyperplasia seen in myelogenous
leukemia.

It would be techinically difficult to locate

the radium close enough to the site of the enlarged
glands in lymphogenous leukemia so that the short
ranged rays of radium would reach the tissue in sufficient
quantity.
Aikins(l) in 1923, expresPed the opinion that
radium therapy in lymphatic leukemia is not as satis
factory as it is in myelogenous leukemia but t�at
lymphatic leukemia was frequently irrproved by radium.
The difficulty in this disease as far a radium therapy
is concerned is that the enlarged glands are usually
so scattered over the bydy that it is difficult to
apply a sufficient dosage of gamma rays.

He does

however remark that this therppy does reduce the white
cell count markedly and sometimes the lymph glands
return to normal• size.
It is obvious that the use of radium in the
treatment of lymphogenous leukemia has liffiitations
which render it impractical for general use.

The

objection is not based any inefficiency of the gamma
rays of radium but only on the techinical difficulty
in delivering those rays.
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Other Radio-active Chemicals:
Since difficulty has been evident in delivering
the gamrra rays of radium to the tissues where their
effects are desired, it has been the project of some
investigators to find a form of chemical which would
both produce those rays and could be delivered to
the tissues where its effects would be of therapeutic
value.
A good number of chemicals have been used.

These

include thorium x, which is given orally; radiothorum,
1h1ch can be given 1ntraverously; and thorodrast,
which can be given intramuscularly.
The work which has been done on the use of radio
active chem1cRls in the treatment of lymphogenous
leukemia is reported for the most part in the German
literature.

There has been very little inclination

of the doctors in this. country to use these chemicals
and very little investigation has been carried out here.
About the only application of these chemicals in the
treatment of lympbogenous leukemia has been o� an
experimental nature.
The danger of using this type of therapy lies
in the fact that once a radio-active chemical is
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placed in the body, it can no longer be removed.
Therefore, when side reaction or actions of over dosage
become apparent, it ls no longer possible to recover
the radio-active cherr.ical and the patient is left
to suffer t he consequence.

There 1s also too little

known about the elimination of these chemicals to warrant
their use as a standard therapeutic measure.
Arsenicals:
The treatment of lymphogenous leukemia by use
of arsenical preperations 1s a tlrr.e honored proceedure.
As far back ae 1865, Lissauer(34) made use of Fowler's

solution, a solution of potassium arsenite,. in treat
ing a patient suffering from leukemia.

He reported

that his patient showed marked symptomatic improvement.
Following Lissauer's report, the standard treat
ment for leukemia consisted of administering Fowler's
solution.

Confirmation of his claims for the chemical

were made by many men.

Until the 11 tera.tur·e on

x-ray therapy in the treatment of lymphogenoue leukemia
appeared, this was the only effective manner of deal
ing with the symptoms of this disease.

Following

the advent of x-ray therapy, the use of Fowler's
and other arsenicals declined to the state or near
extinction.
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Warth1n(60) in 1907, again made use of Fowler's
solution in the treatment of leukemia.

He showed

that the effects of Fowler's solution and roentgen
irradiation were very similar.

He also expressed

the opinion that combined x-ray and arsenical treat
ments were more advantageous than single therapy of
either of the two methods.

he declared that the

p eriod of symptomatic relief was longer and that the
dosage of each type of therapy could be reduced and
still the desired results would be obtained.
Naegeli(41) 1n 1930, objected to the use of
Fowler's solution because of the gastric irritation
which resulted from its use.

He advocated the use of

a preparation of arsenous acid which he claimed was
less toxic and just as effective as Fowler's solution.
In 1931, Forkner and Scott(l7) reviewed and re
studied the use of Fowler's solution in the treatment
of leukemia.

They concluded that in cases of chronic

lymphogenous leukemia, Fowler's solution resul tea in

a considerable reduction in the total leukocyte count
and a decrease in the absolute and percentage values
of immature cells.

They also found that the lymph

nodes and spleen showed some clinical improve�ent.
These rr.en also found that some improvement was
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experienced in certain cases of chronic lymphogenous
leukemia which were refractory to x-ray therapy.
No improvement was seen in cases of acute leukemia
following the use of Fowler's solution.
Benz0l:
In the use of benzol in treating lymphogenous
leukemia we again have a paradoxical situation because
this same substance has been incriminated as being
an etiological agent in the same disease it is used
as a therapeutic agent.
It has long,been known that benzol produces
a toxic response of the hemopoetic system.

Selling(Sl)

in 1916, observed that benzol absorbed by persons
working in industries which use the material, freque!:.tly
had profound ane�la, leukopenia and aplas1a of the
bone ma rr·ow.
In 1912, Koranyi(30) first made use of benzol
in the treatment of leukemia.

He administered from

three to five grarrs of benzol per day by mouth over
periods of several weeks to patients with both chronic
lymphogenous and chronic myelogenous leukemia.

He

obtained a decrease in leukocytei in both types of
leukemia.

He however, also noticed side actions of

the drug which were manifested by a sense of burning
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in the stomach, vomiting, transitory bronchitis and
vertigo.
Kalapos(29) in 1935, compared the use of benzol
and other agents in the treatment of two hundred
leukemic patients.

rte concluded that benzol was as

valuable as x-ray treatffient.

ne also suggested alter

nating x-r-ay and benzol treatment.

He also clairte

that benzol reduced the fever- and siz:e of lymph
nodes or- the spleen much ffiore quickly than did treat
rr:ent with roentgen rays.
There is no modern account in the E.ngliah 11 terature
of the use of benzol in the treatment of lymphogenous
leukemia.

All such accounts are in the German literature.

There are too few accounts and those accounts are
conflicting, so the use of benzol can not be regarded
as accepted standard therapy in lymphogenous leukemia.
Blood Transfusions:
The use of whole blood transfusions in the
treatment of lymphogenous leukemia has some rational
when we consider that f requently u lceration of the
mucoeal surfaces results in blood loss in these patients.
Anemia and its symptoms are effectively compated
by whole blood transfusions.

This is of particular
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value in preparing a patient with this disease for
some operative proceedur-e if such is necessary.
Forkner(l6) in 1938, stated that transfusions
of blood in leukemia should be employed only when indicated
by the anemia.

He says that when transfusions are

indicated, the best results are obtained with use of
relatively large amounts of blood.

He also points

out that this does not prolong the life of the leukemic
patient excepting for a possible few days extension
on the life of the patient suffering from acute leukemia.
Many various types of treatment have been tried
1n order to save the lives of patients suffering from
lymphogenous leukemia.

Only the methods which show

some promise have been presented here.

Unsuccessful

methods wbich have been tried include the use of organs
and extracts of organs o
. f animals, quinine, phosphorus,
antimony, iron, iodine, thyroidectomy, oxygen, ergot,
tuberculin, Coley's toxin, fever therapy, colloidal
gold, sulphur and lead, cinnamic acid, amidopyrine,
heliotherapy, inoculation with malaria, leukotox1ns
and leukolysins.
The wide range of measures employed in the treat
ment of this disease illustrate in themselves the
universal failure of all these methods to halt or cure

-43the disease process in the unfoutunate patient
who 1s suffering from lymphogenous leukemia.

-44su�marv and Conclusions:
Lymphogenous leukemia as an entity was sep�rated
from the general classification of "leukemia"·by
Virchow in about 1846.

Since his time other men have

perfected the diagnosis of the disease to a more
exact state prmncipally by use of refined laboratory
proceedures.
Lymphogenous·leukemia is found to exist in both
man and several species of anirrals.

In man the disease,

both in its acute and chronic forms, is more common
ln the male than the female by a ratio of a.bout three
to one.

The acute form more frequently occurs in the

first decade of 11 fe while the chronic form occurs
more frequently in the third decade of life.
Lymphogenous leukemia has been demonstrated
by isolated exarr.ples to occur in ffiore th�n one member
of a fanily, but these accounts are so rare that little
significance can be placed on the role of heredity
in the etiology of lymphogenous leukemia.
Few cases have been reported wherein the co
existence of neoplastic diseases and lymphogenous
leukemia was found, so it is doubtful if neoplastic
diseases and lymphogenous leukemia often are associated.

-45Its relation to neoplastic diseases of lymphoid origin
is justified on a basis of common origin and rapid
proliferation of lymphoid elements.

It is not

justified on a basis of function and properties of the
involved cells in the neoplastic diseases as compared
to lymphogenous leukemia.
There ls no demonstrated relationship between
lymphogenous leukemia and trauma.
Numerous bacteria have been _recovered and cultured
from patients su.ffer1ng f rom lymphogenous leukemia.
These probably represent secondary invaders and none
of these bacteria have ever been demonstrated to result
in the cause of lymphogenous leukemia 1n man.
Lymphogenous leukemia has been produced by many
chemicals and toxic agents in animals, although never
experimentally in man.

�en working with toxic chemicals

have been reported to develop the disease.
Radiologists and persons closely associated with
x-ray work frequently exhibit a relative lymphocytosis
and two cases of lymphogenous leukemia attri�uted to
x-ray work were cited.
The etiology of lymphogenous leukemia has been
attributed to many factors.

Among these factors there

is an interpretation which can be rriade which would
bind several of these factors together.

The agents

-46of the bacterial theory, the chemicals and toxins and
the x-ray irradiation could all be leading us to the
same thing.

They could all result in a toxic condition

or the tissues and the leukemic picture interpreted to
be the response to that.
The treatment of this disease has been demohstrated
to symptomatic only because so little is known about
the cause of the disease and therefore the cause can
not be combated�.
The more common and effective treatments are
x-ray therapy and the use of arsenicals.

Probably

x-ray 1r·radiation in small frequently repeated dosages
1s the best therapy, but use of Fowler's solution is
important particularly for pract��/I's who are located
in a place where adequate equipment for controled
x-ray therapy 1s not available.
None of our present theray results in prolongation
of the life of the patient suffering from lyrrphogenou�
leukemia and are far from satiefactory.
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